Predict your next investment

ascentcompanies.com

See what CB Insights has to offer

Investments

10

Portfolio Exits

2

About Ascent Private Equity

Ascent Private Equity Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Ascent Private Equity News

Freshtohome Foods’ $121 Million Series C Financing Round

Oct 30, 2020

Freshtohome Pte Ltd completed a series C round of investment led by Ascent Private Equity Trust. Freshtohome Foods Private Limited operates an e-commerce marketplace for fresh chemical-free seafood in India. The company also provides poultry products. The Khaitan & Co team was led by Partner Kartick Maheshwari (Picture), Akshay Bhargav (Partner), Tanushree Bhuwalka (Principal Associate), Aman Dwivedi (Senior Associate) and Tanvi Dabir (Associate).

Ascent Private Equity Investments

10 Investments

Ascent Private Equity has made 10 investments. Their latest investment was in US Stem Cell as part of their Unattributed VC - II on November 11, 2006.

CBI Logo

Ascent Private Equity Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/22/2006

Unattributed VC - II

US Stem Cell

$8M

No

9/7/2005

Series D

US Stem Cell

$19M

No

3/10/2005

Series A - II

Uromedica

$0.1M

No

4/19/2004

Series A

Subscribe to see more

$99M

Subscribe to see more

0

8/12/2002

Series D

Subscribe to see more

$99M

Subscribe to see more

0

Date

11/22/2006

9/7/2005

3/10/2005

4/19/2004

8/12/2002

Round

Unattributed VC - II

Series D

Series A - II

Series A

Series D

Company

US Stem Cell

US Stem Cell

Uromedica

Subscribe to see more

Subscribe to see more

Amount

$8M

$19M

$0.1M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

Ascent Private Equity Portfolio Exits

2 Portfolio Exits

Ascent Private Equity has 2 portfolio exits. Their latest portfolio exit was US Stem Cell on February 20, 2008.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/20/2008

IPO

1

11/10/2005

Acquired

Subscribe to see more

Subscribe to see more

0

Date

2/20/2008

11/10/2005

Exit

IPO

Acquired

Companies

Subscribe to see more

Valuation

Acquirer

Subscribe to see more

Sources

1

0

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.